In this study we aimed to investigate the frequency, titer, efficacy, and kinetics of immunoglobulins response (IgG, IgM, and IgA) of COVID-19 patients, COVID-19 vaccine recipients and random individuals. The gene discussed is CD79A; the disease is COVID-19.